Trametinib plus dabrafenib: Targeting RAS-MAPK pathway for BRAF V600-mutant melanoma

Trametinib plus dabrafenib: Targeting RAS-MAPK pathway for BRAF V600-mutant melanoma

10.2122/gbc.2012.0251

Saved in:
Bibliographic Details
Main Author: Ku, C.-S.
Other Authors: CANCER SCIENCE INSTITUTE OF SINGAPORE
Format: Review
Published: 2014
Online Access:http://scholarbank.nus.edu.sg/handle/10635/116896
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Description
Summary:10.2122/gbc.2012.0251

Similar Items